Month: May 2022

Los Angeles, California, May 17, 2022 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company, reported today its financial results for the first quarter 2022 in an earnings call held on May 13, 2022. Mr. Doug Croxall, Crown’s CEO and Mr. Joel Krutz, CFO, shared with the Company shareholders and industry analysts, the results of the first quarter ending March 31, 2022. In addition to earnings updates, the call also included updates to financing, vertically integrated production, organizational restructuring, and first-generation product delivery. Call highlights:Mr. Croxall delivered a detailed description of the product feature set and capabilities for the first generation and expected second generation Smart Window Inserts™. In...

stā BODY’s First Livestream Shopping Event is Scheduled for May 19, 2022 at 2 p.m. PT The global shapewear market is anticipated to reach USD $3.7 billion by 2028, and stā BODY leverages MARKET’s shoppable livestream capabilities to reach this booming audience. NEWPORT BEACH, Calif. and SALT LAKE CITY, May 17, 2022 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), the leader in interactive video-based sales-enablement applications, including shoppable livestream video, today announced a new partnership with boutique women’s shapewear brand stā BODY. The brand will begin hosting livestream shopping events on MARKET, VERB’s livestream shopping platform, on May 19, 2022 at 2 p.m. PT. The events will be livestreamed from stā BODY’s standalone store on MARKET at stabody.market.live. Created...

STOCKHOLM, SWEDEN, May 17 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has completed the acquisition of the privately-held US-based biotechnology company Atrin Pharmaceuticals Inc. Aprea Therapeutics will now prioritize the development of Atrin Pharmaceuticals’ drug candidates, which are being developed to fight cancer by affecting the proteins involved in the ability of tumors to repair damage to their DNA. With the acquisition of Atrin Pharmaceuticals’ portfolio of candidate drugs, Aprea Therapeutics intends to shift its primary focus to the development of ATRN-119, a drug candidate that inhibits an important signaling pathway in DNA damage repair. ATRN-119 will soon be evaluated in clinical phase 1/2a studies in the treatment of malignant solid tumors, both as monotherapy...

–Prospective location close to coastal shipping and infrastructure to proceed with explorationFigure 1 – Alpha Copper, Okeover (‘Ok”) Property

NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) — Warner Music Group Corp. (“Warner Music Group” or “WMG”) announced today that Eric Levin, Executive Vice President and Chief Financial Officer, will participate in a question and answer session during the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference on Monday, May 23rd, at 1:50 p.m. ET. A live webcast of the session will be available to the general public through a link on the Investor Relations homepage of Warner Music Group’s website (https://investors.wmg.com/events-and-presentations/upcoming-events). A replay of the audio webcast will be available in the Past Events section of Warner Music Group’s Investor Relations homepage. About Warner Music Group With a legacy extending back over 200 years, Warner Music Group (WMG) today brings together artists,...

IRVING, Texas, May 17, 2022 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA) announced the successful completion of its previously announced offer to exchange shares of its Common Stock for its 6.00% Series B Cumulative Convertible Perpetual Preferred Stock (the “Series B Preferred Stock”), with each 20 shares of Common Stock being exchanged for one share of Series B Preferred Stock having a liquidation preference of $25.00 per share (the “Offer”). The Offer expired at 11:59pm, New York City time, on Monday, May 16, 2022 (the “Expiration Date”). Pursuant to the Offer, approximately 41,615,860 shares of Common Stock (excluding shares tendered pursuant to guaranteed delivery procedures) were validly tendered for exchange and not withdrawn as of the Expiration Date. Based on the foregoing, Exela...

Press Release May 17, 2022 Signify’s Annual General Meeting of Shareholders 2022 approves all proposals Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, announces that the Annual General Meeting of Shareholders (AGM) 2022 held today adopted all proposals. Shareholders approved the cash dividend of EUR 1.45 per ordinary share from the 2021 net income. In addition, shareholders approved the appointment of Bram Schot as a member of the Supervisory Board for a period of four years. Signify’s 2021 results are included in its 2021 Annual Report that was published on February 22, 2022. For more information about Signify’s 2022 AGM, please click here. — END — For further information, please contact: Signify Investor RelationsThelke Gerdes +31 6 1801 7131thelke.gerdes@signify.com Signify Corporate...

VERB’s sales enablement platform takes the top spot NEWPORT BEACH, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), the leader in interactive video-based sales enablement applications, including shoppable livestream, is honored to announce its most recent number one ranking. Each month, Social Selling News releases “The Ranks,” a list of companies and people important to the direct selling channel. Its most recent ranking, “Companies that Provide Apps,” selects VERB as the number one direct selling app ranked by the number of clients invoiced over the last 12 months. “This ranking is truly a testament to the hard work that the verbCRM team puts in daily to earn the trust of our many clients,” states McKinley...